ARTICLE | Clinical News
Fanapt iloperidone regulatory update
August 1, 2011 7:00 AM UTC
EMA accepted for review an MAA from Vanda for iloperidone to treat schizophrenia. The serotonin (5-HT2) receptor and dopamine receptor antagonist is marketed in the U.S. as Fanapt for the indication ...